Evaluation of [89Zr]Zr-DFO-2Rs15d Nanobody for Imaging of HER2-Positive Breast Cancer
M Ducharme, L Hall, W Eckenroad… - Molecular …, 2023 - ACS Publications
One of the most aggressive forms of breast cancer involves the overexpression of human
epidermal growth factor receptor 2 (HER2). HER2 is overexpressed in∼ 25% of all breast …
epidermal growth factor receptor 2 (HER2). HER2 is overexpressed in∼ 25% of all breast …
Evaluation of [89Zr] Zr-DFO-2Rs15d Nanobody for Imaging of HER2-Positive Breast Cancer.
M Ducharme, L Hall, W Eckenroad… - Molecular …, 2023 - europepmc.org
One of the most aggressive forms of breast cancer involves the overexpression of human
epidermal growth factor receptor 2 (HER2). HER2 is overexpressed in∼ 25% of all breast …
epidermal growth factor receptor 2 (HER2). HER2 is overexpressed in∼ 25% of all breast …
Evaluation of [89Zr] Zr-DFO-2Rs15d Nanobody for Imaging of HER2-Positive Breast Cancer
M Ducharme, L Hall, W Eckenroad… - Molecular …, 2023 - pubmed.ncbi.nlm.nih.gov
One of the most aggressive forms of breast cancer involves the overexpression of human
epidermal growth factor receptor 2 (HER2). HER2 is overexpressed in∼ 25% of all breast …
epidermal growth factor receptor 2 (HER2). HER2 is overexpressed in∼ 25% of all breast …